OSR Health Corrects Statements Regarding Exchange Approval for Shareholder Reward Program
New York, Friday, 7 August 2026.
OSR Health clarified that stock exchange regulators have not approved its new shareholder reward program, clearing up confusion after misleading initial statements about regulatory endorsement.
Regulatory Clarification Issued
OSR Health, Inc. (NASDAQ:OSRH) released an official statement on August 7, 2026, to clarify previous communications regarding Nasdaq [1]. The company aims to resolve regulatory ambiguities surrounding its Shareholder Loyalty Contingent Value Rights (CVR) Program [1]. This update follows a prior press release issued on July 31, 2026, which had generated confusion regarding regulatory endorsement [1].
Nature of Exchange Communication
The clarification specifies that Nasdaq has not approved or endorsed the Shareholder Loyalty CVR Program [1]. Previous language suggesting affirmation was limited to a preliminary, verbal indication regarding mechanical price adjustments [1]. Nasdaq has not expressed a definitive opinion on the program beyond technical ex-date questions [1].
Loyalty Program Timeline
Despite the regulatory clarification, the August 14, 2026 record date for the program remains unchanged [1]. Shareholders can find enrollment information and eligibility details at the company’s dedicated loyalty program website [1]. The company intends to provide further updates as matters progress [1].
Compliance and Risk Factors
Contextual reports indicate the company received a deficiency notice from Nasdaq regarding listing standards [2]. Forward-looking statements warn of risks related to SEC no-action requests and continued listing status [1]. Investors are advised to consider these factors when evaluating the company’s compliance status [1][2].